annual working capital:
-$2.04B+$3.45B(+62.85%)Summary
- As of today (May 29, 2025), AZN annual working capital is -$2.04 billion, with the most recent change of +$3.45 billion (+62.85%) on December 31, 2024.
- During the last 3 years, AZN annual working capital has fallen by -$5.69 billion (-155.86%).
- AZN annual working capital is now -124.44% below its all-time high of $8.34 billion, reached on December 31, 2010.
Performance
AZN Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
-$2.99B(NaN%)Summary
- As of today (May 29, 2025), AZN quarterly working capital is -$2.99 billion
- Over the past year, AZN quarterly working capital has increased by +$317.00 million (+9.59%).
- AZN quarterly working capital is now -133.77% below its all-time high of $8.85 billion, reached on June 30, 2011.
Performance
AZN quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
AZN Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +62.9% | +9.6% |
3 y3 years | -155.9% | -3115.1% |
5 y5 years | +20.2% | +29.2% |
AZN Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -155.9% | +62.9% | -3115.1% | +50.9% |
5 y | 5-year | -155.9% | +62.9% | -159.2% | +50.9% |
alltime | all time | -124.4% | +62.9% | -133.8% | +66.2% |
AZN Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | -$2.99B(+68.8%) |
Dec 2024 | -$2.04B(-62.8%) | - |
Sep 2024 | - | -$1.77B(-44.2%) |
Jun 2024 | - | -$3.17B(-4.1%) |
Mar 2024 | - | -$3.31B(-45.7%) |
Dec 2023 | -$5.49B(+48.3%) | - |
Sep 2023 | - | -$6.09B(+72.1%) |
Jun 2023 | - | -$3.54B(+36.3%) |
Mar 2023 | - | -$2.59B(-29.9%) |
Dec 2022 | -$3.70B(-201.4%) | -$3.70B(-20.0%) |
Sep 2022 | - | -$4.63B(+415.1%) |
Jun 2022 | - | -$898.00M(+865.6%) |
Mar 2022 | - | -$93.00M(-102.5%) |
Dec 2021 | $3.65B(-578.4%) | $3.65B(+20.0%) |
Sep 2021 | - | $3.04B(-39.8%) |
Jun 2021 | - | $5.05B(-281.9%) |
Mar 2021 | - | -$2.78B(+264.1%) |
Dec 2020 | -$763.00M(-70.1%) | -$763.00M(-1.7%) |
Sep 2020 | - | -$776.00M(-76.1%) |
Jun 2020 | - | -$3.25B(-22.9%) |
Mar 2020 | - | -$4.22B(+65.3%) |
Dec 2019 | -$2.55B(+264.3%) | -$2.55B(+103.3%) |
Sep 2019 | - | -$1.26B(+54.1%) |
Jun 2019 | - | -$815.00M(-82.3%) |
Mar 2019 | - | -$4.61B(+557.2%) |
Dec 2018 | -$701.00M(-78.3%) | -$701.00M(-67.2%) |
Sep 2018 | - | -$2.14B(-55.0%) |
Jun 2018 | - | -$4.75B(-4.6%) |
Mar 2018 | - | -$4.98B(+54.1%) |
Dec 2017 | -$3.23B(+62.1%) | -$3.23B(+290.0%) |
Sep 2017 | - | -$829.00M(-39.0%) |
Jun 2017 | - | -$1.36B(-64.2%) |
Mar 2017 | - | -$3.79B(+90.2%) |
Dec 2016 | -$1.99B(-275.2%) | -$1.99B(-20.7%) |
Sep 2016 | - | -$2.52B(+147.9%) |
Jun 2016 | - | -$1.01B(-67.9%) |
Mar 2016 | - | -$3.16B(-377.9%) |
Dec 2015 | $1.14B(-279.8%) | $1.14B(-140.1%) |
Sep 2015 | - | -$2.84B(+21.3%) |
Jun 2015 | - | -$2.34B(-23.8%) |
Mar 2015 | - | -$3.07B(+384.5%) |
Dec 2014 | -$633.00M(-114.8%) | -$633.00M(-15.8%) |
Sep 2014 | - | -$752.00M(+537.3%) |
Jun 2014 | - | -$118.00M(-87.8%) |
Mar 2014 | - | -$971.00M(-122.7%) |
Dec 2013 | $4.28B(-16.7%) | $4.28B(+4.1%) |
Sep 2013 | - | $4.12B(-1.9%) |
Jun 2013 | - | $4.20B(-6.4%) |
Mar 2013 | - | $4.48B(-12.9%) |
Dec 2012 | $5.14B(-33.6%) | $5.14B(+31.9%) |
Sep 2012 | - | $3.90B(-21.6%) |
Jun 2012 | - | $4.98B(-13.6%) |
Mar 2012 | - | $5.76B(-25.7%) |
Dec 2011 | $7.75B(-7.1%) | $7.75B(-0.7%) |
Sep 2011 | - | $7.81B(-11.8%) |
Jun 2011 | - | $8.85B(+18.8%) |
Mar 2011 | - | $7.45B(-10.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $8.34B(+36.3%) | $8.34B(+8.1%) |
Sep 2010 | - | $7.72B(+9.1%) |
Jun 2010 | - | $7.07B(+32.1%) |
Mar 2010 | - | $5.35B(-12.5%) |
Dec 2009 | $6.12B(+149.4%) | $6.12B(+12.8%) |
Sep 2009 | - | $5.42B(+36.2%) |
Jun 2009 | - | $3.98B(+120.9%) |
Mar 2009 | - | $1.80B(-26.5%) |
Dec 2008 | $2.45B(+29.5%) | $2.45B(+120.3%) |
Sep 2008 | - | $1.11B(+129.7%) |
Jun 2008 | - | $485.00M(-139.4%) |
Mar 2008 | - | -$1.23B(-164.9%) |
Dec 2007 | $1.90B(-74.7%) | $1.90B(-326.4%) |
Sep 2007 | - | -$837.00M(-90.5%) |
Jun 2007 | - | -$8.86B(-249.1%) |
Mar 2007 | - | $5.94B(-20.7%) |
Dec 2006 | $7.49B(+8.1%) | $7.49B(+18.0%) |
Sep 2006 | - | $6.34B(-4.5%) |
Jun 2006 | - | $6.65B(-11.3%) |
Mar 2006 | - | $7.49B(+8.1%) |
Dec 2005 | $6.93B(+7.7%) | $6.93B(+9.1%) |
Sep 2005 | - | $6.35B(-4.3%) |
Jun 2005 | - | $6.64B(-4.2%) |
Mar 2005 | - | $6.93B(+7.7%) |
Dec 2004 | $6.44B(+22.9%) | $6.44B(+17.2%) |
Sep 2004 | - | $5.49B(+10.9%) |
Jun 2004 | - | $4.95B(-10.2%) |
Mar 2004 | - | $5.51B(+5.3%) |
Dec 2003 | $5.24B(+33.9%) | $5.24B(-11.2%) |
Sep 2003 | - | $5.90B(+14.7%) |
Jun 2003 | - | $5.14B(+7.4%) |
Mar 2003 | - | $4.79B(+22.5%) |
Dec 2002 | $3.91B(+0.7%) | $3.91B(-15.5%) |
Sep 2002 | - | $4.63B(+8.8%) |
Jun 2002 | - | $4.26B(-6.3%) |
Mar 2002 | - | $4.54B(+16.9%) |
Dec 2001 | $3.88B(+7.3%) | $3.88B(-18.3%) |
Sep 2001 | - | $4.76B(+6.1%) |
Jun 2001 | - | $4.48B(+0.1%) |
Mar 2001 | - | $4.48B(+23.6%) |
Dec 2000 | $3.62B(+25.1%) | $3.62B(-7.7%) |
Sep 2000 | - | $3.92B(+13.6%) |
Jun 2000 | - | $3.45B(-4.4%) |
Mar 2000 | - | $3.61B(+24.8%) |
Dec 1999 | $2.90B(-22.9%) | $2.90B(-31.2%) |
Sep 1999 | - | $4.21B(+10.6%) |
Jun 1999 | - | $3.81B(+1.4%) |
Dec 1998 | $3.75B(+128.7%) | $3.75B(+152.6%) |
Jun 1998 | - | $1.49B(-9.5%) |
Dec 1997 | $1.64B(-17.7%) | $1.64B(-17.7%) |
Dec 1996 | $2.00B(+14.9%) | $2.00B(+14.9%) |
Dec 1995 | $1.74B(+9.7%) | $1.74B(-1.2%) |
Jun 1995 | - | $1.76B(+10.9%) |
Dec 1994 | $1.58B(+12.8%) | $1.58B(+12.8%) |
Dec 1993 | $1.40B(-817.5%) | $1.40B |
Dec 1992 | -$195.65M(-109.6%) | - |
Dec 1991 | $2.04B(+5.6%) | - |
Dec 1990 | $1.93B | - |
FAQ
- What is AstraZeneca annual working capital?
- What is the all time high annual working capital for AstraZeneca?
- What is AstraZeneca annual working capital year-on-year change?
- What is AstraZeneca quarterly working capital?
- What is the all time high quarterly working capital for AstraZeneca?
- What is AstraZeneca quarterly working capital year-on-year change?
What is AstraZeneca annual working capital?
The current annual working capital of AZN is -$2.04B
What is the all time high annual working capital for AstraZeneca?
AstraZeneca all-time high annual working capital is $8.34B
What is AstraZeneca annual working capital year-on-year change?
Over the past year, AZN annual working capital has changed by +$3.45B (+62.85%)
What is AstraZeneca quarterly working capital?
The current quarterly working capital of AZN is -$2.99B
What is the all time high quarterly working capital for AstraZeneca?
AstraZeneca all-time high quarterly working capital is $8.85B
What is AstraZeneca quarterly working capital year-on-year change?
Over the past year, AZN quarterly working capital has changed by +$317.00M (+9.59%)